BEIJING, July 30, 2013 /PRNewswire-FirstCall/ -- China
Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the
"Company"), a leading fully integrated plasma-based
biopharmaceutical company in China, today announced that the Company plans
to release second quarter 2013 financial results on Tuesday, August 6, 2013 after the market
closes.
The Company's management will hold a conference call at
7:30 a.m. ET on Wednesday, August 7, 2013 to discuss second
quarter 2013 results. Listeners may access the call by dialing
1-480-629-9664. A live and archived webcast of the conference call
will be available through the Company's investor relations website
at http://chinabiologic.investorroom.com/. A replay of the call
will be available through August 21,
2013 by dialing 1-858-384-5517, access code: 4633951.
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully
integrated plasma-based biopharmaceutical company in China. The Company's products are used as
critical therapies during medical emergencies and for the
prevention and treatment of life-threatening diseases and
immune-deficiency related diseases. China Biologic is headquartered
in Beijing and manufactures over
20 plasma-based products through its indirect majority-owned
subsidiaries, Shandong Taibang Biological Products Co., Ltd. and
Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has
an equity investment in Xi'an Huitian Blood Products Co., Ltd. The
Company sells its products to hospitals and other healthcare
facilities in China. For
additional information, please see the Company's website
www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Vice President
Phone: +86-10-6598-3099
Email: ir@chinabiologic.com
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: william.zima@icrinc.com
SOURCE China Biologic Products, Inc.